| REX-ULTI OTSUKA PHARMACEUTICAL CO. LTD.
1746031 15 Sep 2015 | on 03 Oct 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; central nervous system stimulants to increase physical activity, mental alertness and attention span; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely, Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; diagnostic reagents for medical diagnostic use. | | | REX-ULTI BREXPIPRAZOLE & DOUBLE TRIANGLE DESIGN OTSUKA PHARMACEUTICAL CO. LTD.
1746407 17 Sep 2015 | on 10 Oct 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; central nervous system stimulants to increase physical activity, mental alertness and attention span; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely, Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; diagnostic reagents for medical diagnostic use. | | 
